Research on quaternary ammonium compounds (QACs) has shown promising results in combating MRSA, a drug-resistant bacterium. Studies have found that QACs effectively kill MRSA by disrupting the bacterial cell membrane, leading to cell death. Various methodologies, including in vitro and in vivo experiments, have been used to demonstrate the efficacy of QACs against MRSA. The implications of these findings are significant as they suggest that QACs could be a potential solution for treating MRSA infections, especially in healthcare settings where the bacterium is prevalent. Further research is needed to explore the full potential of QACs and their application in clinical settings to combat the growing threat of antibiotic resistance.